Sørensen H A, Schwarz P, Hyldstrup L, Transbøl I
Copenhagen Osteoporosis Research Centre, Denmark.
Clin Endocrinol (Oxf). 1994 Mar;40(3):309-15. doi: 10.1111/j.1365-2265.1994.tb03924.x.
Induced aggravation of hypercalcaemia in vivo and in vitro causes partial suppression of parathyroid hormone (PTH) secretion in primary hyperparathyroidism (PHP). Furthermore, one in-vitro study also demonstrates progressive escape from such action. The aim of the present in-vivo study was to examine whether escape from suppression is a common feature of PHP.
A rapid increment in blood ionized calcium (B-Ca2+) to 0.25-0.30 mmol/l above individual baselines was achieved by intravenous calcium infusions. This induced or aggravated hypercalcaemia was kept constant for 2 hours (controls) or 4 hours (patients).
The study of PHP comprised 19 patients (18 females and one male) aged 39-85 years (geometric mean 66). For comparison we included the results obtained in a control group of 24 healthy subjects (11 women and 13 men) aged 20-68 years (geometric mean 32).
The individual levels of B-Ca2+ were controlled by frequent bedside measurements of B-Ca2+. The changes in serum intact parathyroid hormone (S-PTH(1-84)) were registered.
After 30 minutes of calcium infusion average concentrations of S-PTH(1-84) had decreased from 7.9 (6.7-9.4) pmol/l in PHP and 2.5 (2.1-2.9) pmol/l in controls to their respective nadir values of 2.9 (2.1-4.1) pmol/l and 0.6 (0.5-0.8) pmol/l. While S-PTH(1-84) remained suppressed at a stable level for 120 minutes in controls, in PHP it started to escape progressively after 30 minutes to a level of 4.2 (3.0-5.8) pmol/l (P < 0.001). Linear regression analysis of the individual S-PTH(1-84) observations in PHP, from 30 to 240 minutes of study, revealed that five patients did not escape (group A) while the remainder 14 patients escaped progressively (group B). Within group B, seven patients escaped significantly after 120 minutes, 10 after 180 minutes and 14 after 240 minutes. Although comparable respecting B-Ca2+ before and during calcium infusion, group A and B presented different S-PTH(1-84) curves. Thus, at times zero, 30, 120 and 240 minutes their respective average concentrations of S-PTH(1-84) measured 9.9 (9.1-10.9) vs 7.3 (5.9-9.0) (P < 0.02), 4.6 (3.7-5.7) vs 2.5 (1.6-3.9) (P < 0.01), 5.0 (3.9-6.5) vs 3.0 (1.9-4.8) (P < 0.05) and 5.2 (3.6-7.4) vs 3.9 (2.6-6.0) (NS) pmol/l.
We hypothesize that two different mechanisms are involved in the parathyroid response to the calcium clamp, an initial and fast inhibition of PTH release, while the subsequent course depends on the balance between the intra-glandular secretion rate of PTH and the intra-glandular capacity for PTH degradation. The escape from parathyroid suppression during a sustained stable increment in B-Ca2+ suggests that the basal secretion over-rides degradation in a majority of the patients with PHP.
体内和体外诱导的高钙血症加重会导致原发性甲状旁腺功能亢进症(PHP)中甲状旁腺激素(PTH)分泌部分受抑制。此外,一项体外研究还表明存在对此种作用的渐进性逃逸现象。本体内研究的目的是检验逃逸抑制是否为PHP的一个常见特征。
通过静脉输注钙剂,使血液离子钙(B-Ca2+)迅速升高至高于个体基线水平0.25 - 0.30 mmol/l。这种诱导或加重的高钙血症在2小时(对照组)或4小时(患者组)内保持恒定。
PHP研究纳入了19例患者(18例女性和1例男性),年龄39 - 85岁(几何均数66岁)。为作比较,我们纳入了24名健康受试者(11名女性和13名男性)作为对照组的结果,年龄20 - 68岁(几何均数32岁)。
通过床旁频繁测量B-Ca2+来控制个体的B-Ca2+水平。记录血清完整甲状旁腺激素(S-PTH(1 - 84))的变化。
输注钙剂30分钟后,PHP组S-PTH(1 - 84)的平均浓度从7.9(6.7 - 9.4)pmol/l降至最低点2.9(2.1 - 4.1)pmol/l,对照组从2.5(2.1 - 2.9)pmol/l降至最低点0.6(0.5 - 0.8)pmol/l。对照组中S-PTH(1 - 84)在120分钟内保持稳定的抑制水平,而在PHP组中,30分钟后开始逐渐逃逸至4.2(3.0 - 5.8)pmol/l(P < 0.001)。对PHP组研究30至240分钟内个体S-PTH(1 - 84)观察值进行线性回归分析显示,5例患者未发生逃逸(A组),其余14例患者逐渐逃逸(B组)。在B组中,7例患者在120分钟后显著逃逸,10例在180分钟后逃逸,14例在240分钟后逃逸。尽管A组和B组在输注钙剂前后的B-Ca2+水平具有可比性,但它们的S-PTH(1 - 84)曲线不同。因此,在0、30、120和240分钟时,它们各自的S-PTH(1 - 84)平均浓度分别为9.9(9.1 - 10.9)与7.3(5.9 - 9.0)(P < 0.02)、4.6(3.7 - 5.7)与2.5(1.6 - 3.9)(P < 0.01)、5.0(3.9 - 6.